Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response

Juan Montoro; Daniele Laszlo; Natalia Pin Chuen Zing; Giuseppe Petralia; Giorgio Conte; Marzia Colandrea; Giovanni Martinelli; Lorenzo Preda

doi:10.3332/ecancer.2014.429

Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response

Ecancermedicalscience. 2014 May 15:8:429. doi: 10.3332/ecancer.2014.429. eCollection 2014.

Authors

Juan Montoro¹, Daniele Laszlo¹, Natalia Pin Chuen Zing¹, Giuseppe Petralia², Giorgio Conte³, Marzia Colandrea⁴, Giovanni Martinelli¹, Lorenzo Preda²

Affiliations

¹ Division of Clinical Haematology/Oncology, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy.
² Division of Radiology, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy.
³ Department of Health Science, University of Milan, Milan 20216, Italy.
⁴ Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, Milan 20141, Italy.

Abstract

Computed tomography (CT), 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), and hybrid FDG-PET/CT are the most commonly used diagnostic tools for the initial staging and treatment response assessment of lymphomas [1]. The aim of this report is to compare the correlations between functional imaging markers derived from FDG-PET/CT and whole-body, diffusion-weighted magnetic resonance imaging (DW-MRI) in a young patient affected by Hodgkin's lymphoma (HL).

Keywords: Hodgkin’s lymphoma; PET/CT; whole-body diffusion-weighted magnetic resonance.